Dr. John Bilbily, MD

Dr. Bilbily practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Bilbily's NPI, 1912427568, was assigned on June 25, 2017. Dr. Bilbily holds Missouri license 2021023195.

Dr. Bilbily's primary practice is Washington University School of Medicine, at 4444 Forest Park Ave, Saint Louis, MO 63108 in Saint Louis City. The practice phone is (314) 445-7757.

Dr. Bilbily's primary practice is Washington University School of Medicine in Saint Louis, Missouri. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Bilbily to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account. Dr. Bilbily's employer is on file too: a physical therapy & rehab clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bilbily practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Bilbily's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Bilbily is licensed in Missouri.

CMS data shows 30 Medicare services from Dr. Bilbily across 1 procedure code in 2024, for 22 Medicare patients. Medicare paid $1,747 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Bilbily in 2024. The largest group is under 65, with 11 patients. 75% of them have mood disorders, and 73% have high blood pressure. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bilbily's median patient age at 40, with 56% women.

In 2024, Dr. Bilbily wrote 83 Medicare Part D claims for 27 patients. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $120 in total drug cost. In 2021, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bilbily for performance year 2024, reported as part of a group. Dr. Bilbily accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bilbily as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Bilbily from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $127.